Review of therapeutic agents for the treatment of COVID-19
Shadi Ziaie, Mehran Koucheck, Mir Mohammad Miri, Sara Salarian, Seyedpouzhia Shojaei, Mehrdad Haghighi, Mohammad Sistanizad
Abstract
In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China, named coronavirus disease 2019 (COVID -19) which has been spreading in 204 countries. In this review, the mains pharmaceutical option quoted previously and especially available for ICU patients are reviewed.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Pneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusMedicineCluster (spacecraft)Intensive care medicinePandemicDiseaseVirologyInfectious disease (medical specialty)Internal medicineComputer scienceOutbreakProgramming languageCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacological Receptor Mechanisms and Effects